Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism PKM2 inhibitors(Pyruvate kinase isozymes M1/M2 inhibitors), SSTR1 agonists(Somatostatin receptor 1 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC45H58N10O9S2 |
InChIKeySNAJPQVDGYDQSW-DYCFWDQMSA-N |
CAS Registry147159-51-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Phase 2 | CA | 02 Sep 2009 | |
Metastatic melanoma | Phase 2 | US | 01 Aug 2008 | |
Metastatic melanoma | Phase 2 | CA | 01 Aug 2008 | |
Metastatic Renal Cell Carcinoma | Phase 2 | FR | 01 Mar 2007 | |
Neoplasms | Phase 2 | US | 20 Oct 2002 | |
Kidney Neoplasms | Phase 2 | FR | - |